ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...
Among other functions, the NK cells (natural killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot ...
19h
News-Medical.Net on MSNResearchers develop tool to enhance NK cells against cancerA team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells ...
20h
Zacks Investment Research on MSNIllumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?Illumina, Inc. ILMN and Nashville Biosciences, LLC (NashBio) recently announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. The insights ...
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...
The CME-accredited event will take place at Atlantis The Palm and Atlantis The Royal from April 23-27, bringing together the world's leading healthcare and wellness experts ...
As a BCMA-targeting CAR T-cell therapy, CARVYKTI addresses a high unmet need in relapsed or refractory multiple myeloma patients. With promising clinical efficacy, durable responses, and growing ...
The global virology market is on track for significant expansion, with projections indicating a steady rise from USD 2,333.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results